Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression.
The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of ...

https://www.business-standard.com/article/companies/alembic-pharmaceuticals-gets-usfda-nod-for-bipolar-depression-drug-121051400462_1.html

#business-standard